نتائج البحث - "Antirheumatic Agents adverse effects"

1

Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study

المؤلفون: Jon Erik Fraes Diernæs, Charles B. Kromann, Mikkel Boel, Anette Bygum, Gregor Borut Ernst Jemec

المصدر: Fraes Diernæs, J E, Kromann, C B, Boel, M, Bygum, A & Jemec, G B E 2022, ' Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate : A prospective, multicenter, paired cohort study ', Journal of the American Academy of Dermatology, vol. 87, no. 4, pp. 920-922 . https://doi.org/10.1016/j.jaad.2021.12.039

مصطلحات موضوعية: Cohort Studies, Methotrexate/adverse effects, Methotrexate, Treatment Outcome, Antirheumatic Agents, Injections, Subcutaneous, Administration, Oral, Humans, Patient Reported Outcome Measures, Prospective Studies, Dermatology, Antirheumatic Agents/adverse effects

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fffcaaa45376501e05fe607314660fee
https://doi.org/10.1016/j.jaad.2021.12.039

View record from ScienceDirect

Full Text via ClinicalKey

2

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

المؤلفون: Rene Lindholm Cordtz, Johan Askling, Benedicte Delcoigne, Karin E Smedby, Eva Baecklund, Christine Ballegaard, Pia Isomäki, Kalle Aaltonen, Bjorn Gudbjornsson, Thorvardur Jon Love, Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Lene Dreyer, Karin Hellgren

المساهمون: Tampere University, Department of Internal medicine, Clinical Medicine

المصدر: Cordtz, R L, Askling, J, Delcoigne, B, Smedby, K E, Baecklund, E, Ballegaard, C, Isomäki, P, Aaltonen, K, Gudbjornsson, B, Love, T J, Provan, S A, Michelsen, B, Sexton, J, Dreyer, L & Hellgren, K 2022, ' Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors : a Nordic cohort study ', RMD Open, vol. 8, no. 2, e002776 . https://doi.org/10.1136/rmdopen-2022-002776

وصف الملف: fulltext; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fecae795960b66f3d5ca6deb42db079
https://pubmed.ncbi.nlm.nih.gov/36564101

Find this article in full text from ProQuest

3

Biologisk terapi ved juvenil idiopatisk artritis

المؤلفون: Neve-Græsbøll, Amalie, Glerup, Mia, Herlin, Troels

المصدر: Neve-Græsbøll, A, Glerup, M & Herlin, T 2022, ' Biologisk terapi ved juvenil idiopatisk artritis ', Ugeskrift for Læger, bind 184, nr. 13, V03210290 .

مصطلحات موضوعية: Biological Products/adverse effects, Biological Therapy, Treatment Outcome, Adolescent, Humans, Arthritis, Juvenile/chemically induced, Antirheumatic Agents/adverse effects, Child

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d97c78d7b571003180cb0e8f4972322d
https://pure.au.dk/ws/files/331221371/Biologisk_terapi_ved_juvenil_idiopatisk_artritis.pdf

4

Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al

المؤلفون: Henning Locht, Melinda Magyari, Dorte Vendelbo Jensen, Finn Sellebjerg, Lene Dreyer, René Cordtz, Tine Iskov Kopp, Johan Askling, Bénédicte Delcoigne, Elizabeth V. Arkema

المصدر: Kopp, T I, Delcoigne, B, Arkema, E V, Magyari, M, Locht, H, Sellebjerg, F T, Cordtz, R L, Jensen, D V, Askling, J & Dreyer, L 2022, ' Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al ', Annals of the Rheumatic Diseases, vol. 81, no. 5, e74, pp. E74 . https://doi.org/10.1136/annrheumdis-2020-217802

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Immunology, Arthritis, Psoriatic/drug therapy, Tumour necrosis factor alpha, Antirheumatic Agents/adverse effects, General Biochemistry, Genetics and Molecular Biology, Etanercept, 03 medical and health sciences, Neurological assessment, 0302 clinical medicine, Rheumatology, Etanercept/therapeutic use, Internal medicine, Epidemiology, Spondylitis, Ankylosing/drug therapy, Brain mri, medicine, Immunology and Allergy, Humans, Spondylitis, Ankylosing, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, Arthritis, Psoriatic, 030104 developmental biology, Antirheumatic Agents, Tumor necrosis factor alpha, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7086c5d5631e5c304999a4eeee4d4e8
https://vbn.aau.dk/da/publications/c9ebf8dc-0f3a-4a18-9b19-40e91023d53a

5

Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis:a nationwide nested case-control study

المؤلفون: Sabine Sparre Dieperink, Frank Mehnert, Mette Nørgaard, Louise Bruun Oestergaard, Thomas Benfield, Andreas Petersen, Christian Torp-Pedersen, Bente Glintborg, Merete Lund Hetland

المصدر: Dieperink, S S, Mehnert, F, Nørgaard, M, Oestergaard, L B, Benfield, T, Petersen, A, Torp-Pedersen, C, Glintborg, B & Hetland, M L 2022, ' Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis : a nationwide nested case-control study ', RMD Open, vol. 8, no. 2, 002636 . https://doi.org/10.1136/rmdopen-2022-002636
Dieperink, S S, Mehnert, F, Nørgaard, M, Oestergaard, L B, Benfield, T, Petersen, A, Torp-Pedersen, C, Glintborg, B & Hetland, M L 2022, ' Antirheumatic treatment, disease activity and risk of Staphylococcus aureus bacteraemia in rheumatoid arthritis : a nationwide nested case-control study ', RMD open, vol. 8, no. 2, e002636 . https://doi.org/10.1136/rmdopen-2022-002636

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29d4b26aa82ce91e6c93e2054ab9b649
https://curis.ku.dk/ws/files/331443720/Fulltext.pdf

6

Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID ‐19

المؤلفون: Laura Eades, Sally Ayoub, William Tillett, Kathryn Connelly, Thilinie De Silva, Eric F Morand, Anna Antony

المصدر: Antony, A, Connelly, K, De Silva, T, Eades, L, Tillett, W, Ayoub, S & Morand, E 2020, ' Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID-19 ', Arthritis Care & Research, vol. 72, no. 9, pp. 1189-1195 . https://doi.org/10.1002/acr.24347
Arthritis Care & Research

مصطلحات موضوعية: Male, Drug, medicine.medical_specialty, media_common.quotation_subject, Pneumonia, Viral, Coronavirus Infections/prevention & control, Rheumatic Diseases/drug therapy, Telehealth, Disease, Antirheumatic Agents/adverse effects, Severity of Illness Index, Patient Acceptance of Health Care/psychology, Medication Adherence, Betacoronavirus, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Rheumatic Diseases, Surveys and Questionnaires, Internal medicine, Severity of illness, Pandemic, medicine, Humans, Infection control, Pandemics/prevention & control, Pandemics, media_common, 030203 arthritis & rheumatology, Pneumonia, Viral/prevention & control, SARS-CoV-2, business.industry, Brief Report, COVID-19, Patient Acceptance of Health Care, Middle Aged, Antirheumatic Agents, Emergency medicine, Prednisolone, Brief Reports, Female, Coronavirus Infections, business, Attitude to Health, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735051713f1f8476a2e21b519fbaf0e6
https://doi.org/10.1002/acr.24347

View record at Wiley

7

رسالة جامعية

Anti-TNF therapy and malignancy in patients with rheumatoid arthritis : studies on incidence, recurrence and survival

المؤلفون: Raaschou, Pauline

مصطلحات موضوعية: Arthritis, Rheumatoid -- drug therapy, Arthritis, Rheumatoid -- epidemiology, Tumor Necrosis Factors -- adverse effects, Tumor Necrosis Factors -- antagonists & inhibitors, Tumor Necrosis Factors -- therapeutic use, Antirheumatic Agents -- adverse effects, Antirheumatic Agents -- therapeutic use, Antibodies, Monoclonal -- adverse effects, Antibodies, Monoclonal -- therapeutic use, Recurrence, Survival, Skin Neoplasms -- chemically induced, Skin Neoplasms -- epidemiology, Breast Neoplasms -- chemically induced, Breast Neoplasms -- epidemiology, Risk Assessment

Degree: Diss. (sammanfattning) Stockholm : Karolinska Institutet, 2014

8

Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced

المؤلفون: S. Sheng, Philip S. Helliwell, Enrique R. Soriano, Yanli Zhuang, Soumya D. Chakravarty, May Shawi, Atul Deodhar, Y. Jiang, Chetan S Karyekar, Christopher T. Ritchlin, Elizabeth C. Hsia, Federico Zazzetti, B. Zhou, Qing C. Zuraw, Wolf-Henning Boehncke, Prasheen Agarwal, Ramanand A Subramanian, Xie L. Xu, A. Kollmeier

المصدر: RMD open, Vol. 7, No 1 (2021) P. e001457
RMD Open, Vol 7, Iss 1 (2021)
RMD Open

مصطلحات موضوعية: Adult, medicine.medical_specialty, tumor necrosis factor inhibitors, Psoriatic Arthritis, Immunology, Arthritis, Psoriatic, Placebo, Antibodies, Monoclonal, Humanized, Inflammatory bowel disease, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Immunology and Allergy, Humans, Biological therapy, Adverse effect, Arthritis, Psoriatic / drug therapy, 030203 arthritis & rheumatology, ddc:616, Biological Products, biology, business.industry, Standard treatment, Arthritis, Psoriatic, C-reactive protein, medicine.disease, Tumor necrosis factor inhibitors, cytokines, Guselkumab, arthritis, biological therapy, Antirheumatic Agents, biology.protein, Interleukin-23 Subunit p19, Quality of Life, Medicine, Cytokines, Antirheumatic Agents / adverse effects, Biological Products / therapeutic use, psoriatic, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d19d211b9a061a28a692d7d286efaa
https://archive-ouverte.unige.ch/unige:159820

Find this article in full text from ProQuest

9

Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial

المؤلفون: Diederik De Cock, D. Bertrand, Patrick Verschueren, Annelies Boonen, Rene Westhovens, Johan Joly, S. Pazmino, Veerle Stouten

المساهمون: RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation, Interne Geneeskunde, MUMC+: MA Reumatologie (9), Public Health Sciences

المصدر: RMD Open, 7(2):e001615. BMJ Publishing Group
RMD Open, Vol 7, Iss 2 (2021)
RMD Open

مصطلحات موضوعية: Glucocorticoids/therapeutic use, medicine.medical_specialty, rheumatoid, Methotrexate/therapeutic use, Immunology, Analgesic, Arthritis, Cobra, Rheumatoid Arthritis, Antirheumatic Agents/adverse effects, law.invention, Arthritis, Rheumatoid, Randomized controlled trial, Rheumatology, law, Internal medicine, medicine, Immunology and Allergy, Humans, computer.programming_language, COMBINATION-TREATMENT STRATEGIES, Science & Technology, glucocorticoids, business.industry, Anti-Inflammatory Agents, Non-Steroidal, medicine.disease, Acetaminophen, Methotrexate, arthritis, Rheumatoid arthritis, Antirheumatic Agents, Analgesics/therapeutic use, Arthritis, Rheumatoid/diagnosis, analgesics, Medicine, Drug Therapy, Combination, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Tramadol, business, computer, Life Sciences & Biomedicine, medicine.drug